Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 May;36(5):249-54.
doi: 10.1002/clc.22104. Epub 2013 Mar 25.

Tricuspid regurgitation in patients with pacemakers and implantable cardiac defibrillators: a comprehensive review

Affiliations
Review

Tricuspid regurgitation in patients with pacemakers and implantable cardiac defibrillators: a comprehensive review

Rasha Al-Bawardy et al. Clin Cardiol. 2013 May.

Abstract

Implantable cardiac devices, including defibrillators and pacemakers, may be the cause of tricuspid regurgitation (TR) or may worsen existing TR. This review of the literature suggests that TR usually occurs over time after lead implantation. Diagnosis by clinical exam and 2-dimensional echocardiography may be augmented by 3-dimensional echocardiography and/or computed tomography. The mechanism may be mechanical perforation or laceration of leaflets, scarring and restriction of leaflets, or asynchronized activation of the right ventricle. Pacemaker-related TR might cause severe right-sided heart failure, but data regarding associated mortality are lacking. This comprehensive review summarizes the data regarding incidence, mechanism, and treatment of lead-related TR.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mechanisms of mechanical tricuspid regurgitation in the setting of permanent pacemaker or implantable cardioverter‐defibrillator leads. (a) Valve obstruction caused by lead placed in between leaflets. (b) Lead adherence due to fibrosis and scar formation to valve causing incomplete closure. (c) Lead entrapment in the tricuspid valve apparatus. (d) Valve perforation or laceration. (e) Annular dilatation.

References

    1. Agarwal S, Tuzcu E, Rodriguez E, et al. Interventional cardiology perspective of functional tricuspid regurgitation. Circ Cardiovasc Interv. 2009;2:565–573. - PubMed
    1. Gibson TC, Davidson RC, DeSilvey DL. Presumptive tricuspid valve malfunction induced by a pacemaker lead: a case report and review of the literature. Pacing Clin Electrophysiol. 1980;3:88–95. - PubMed
    1. Seo Y, Ishizu T, Nakajima H, et al. Clinical utility of 3‐dimensional echocardiography in the evaluation of tricuspid regurgitation caused by pacemaker leads. Circ J. 2008;72:1465–1470. - PubMed
    1. Paniagua D, Aldrich HR, Lieberman EH, et al. Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemakers leads. Am J Cardiol. 1998;82:1130–1132, A9. - PubMed
    1. De Cock CC, Vinkers M, Van Campe LC, et al. Long‐term outcome of patients with multiple (≥3) noninfected transvenous leads: a clinical and echocardiographic study. Pacing Clin Electrophysiol. 2000;23:423–426. - PubMed

MeSH terms

LinkOut - more resources